Arc Therapeutics partners with hospitals to establish specialty centers for the management and treatment of metastatic brain tumors. The company provides turnkey radiosurgical solutions, including the installation of Zap-X radiosurgical units, facility design, financial and operational support, clinical training, and multidisciplinary care coordination for cancer patients.
Subscribe to see Arc Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arc Therapeutics is a drug discovery company headquartered in Singapore. Xcout tracks 3 named people at Arc Therapeutics, including H. Warren Goldman (Chief Medical Executive).
A few of Arc Therapeutics's closest competitors — see the full list of competitors and alternatives →
Artiria Medical is a medical technology company founded in 2019 and headquartered in Borex, Switzerland. The company develops cutting-edge technologies that empower catheters and guidewires to enable precise micromotion deep inside brain arteries.
Convergent Therapeutics, Inc. is a biotechnology research company based in Cambridge, Massachusetts, focused on developing next-generation targeted radiotherapies and combination therapies to treat cancer.
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Fusion Pharmaceuticals is a pharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer patients.
AcelRx Pharmaceuticals, Inc., which has rebranded as Talphera, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies and products for use in medically supervised settings.
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.